Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy.

Seung Hyuck JeonKyung Hwan ShinJin Ho KimKyubo KimIn Ah KimKyung-Hun LeeTae-Yong KimSeock-Ah Im

Published in: Breast cancer research and treatment (2018)

Adjuvant trastuzumab improved LRC in patients with HER2-overexpressing breast cancer receiving adjuvant RT and cytotoxic chemotherapy, especially in hormone receptor-negative, HER2-enriched subtype, and high positive lymph node ratio breast cancer.

Keyphrases

epidermal growth factor receptor
early stage
lymph node
tyrosine kinase
locally advanced
advanced non small cell lung cancer
endothelial cells
neoadjuvant chemotherapy
radiation therapy
rectal cancer
young adults
metastatic breast cancer